Low-dose rivaroxaban: can cardiovascular events be reduced?

被引:5
作者
De Luca, Leonardo [1 ,2 ]
机构
[1] AO San Camillo Forlanini, Dept Cardiothorac & Vasc Med & Surg, Div Cardiol, Circonvallaz Gianicolense 87, I-0052 Rome, Italy
[2] UniCamillus St Camillus Int Univ Hlth Sci, Via St Alessandro 8, I-00131 Rome, Italy
关键词
Rivaroxaban; Peripheral artery disease; Coronary artery disease; COMPASS trial; PERIPHERAL ARTERY-DISEASE; CHRONIC CORONARY; PLUS ASPIRIN; DOUBLE-BLIND; COMPASS;
D O I
10.1093/eurheartjsupp/suad034
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite available effective guideline-based preventive therapies, patients with vascular diseases remain at high-risk of recurrent ischaemic events. Novel therapeutic strategies are therefore needed in order to further reduce the residual risk that is present in these high-risk patients. The Cardiovascular Outcomes for People using Anticoagulation Strategies trial demonstrated that, in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), a combination of rivaroxaban 2.5 mg/bid (vascular dose) and acetylsalicylic acid (ASA) 100 mg once daily, the so-called dual pathway inhibition (DPI), reduced cardiovascular death, stroke, or myocardial infarction by 24% and mortality by 18%, as compared with ASA-alone. The rationale that can explain the improvement of cardiovascular outcome is that platelet aggregation and fibrin formation are involved in arterial thrombosis and rivaroxaban is able to target both ways and has a synergic effect with ASA. The aim of this review is to discuss the potential mechanisms and added benefits of DPI, in patients with PAD and CAD.
引用
收藏
页码:C20 / C26
页数:7
相关论文
共 20 条
[1]   Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial [J].
Anand, Sonia S. ;
Bosch, Jackie ;
Eikelboom, John W. ;
Connolly, Stuart J. ;
Diaz, Rafael ;
Widimsky, Peter ;
Aboyans, Victor ;
Alings, Marco ;
Kakkar, Ajay K. ;
Keltai, Katalin ;
Maggioni, Aldo P. ;
Lewis, Basil S. ;
Stoerk, Stefan ;
Zhu, Jun ;
Lopez-Jaramillo, Patricio ;
O'Donnell, Martin ;
Commerford, Patrick J. ;
Vinereanu, Dragos ;
Pogosova, Nana ;
Ryden, Lars ;
Fox, Keith A. A. ;
Bhatt, Deepak L. ;
Misselwitz, Frank ;
Varigos, John D. ;
Vanassche, Thomas ;
Avezum, Alvaro A. ;
Chen, Edmond ;
Branch, Kelley ;
Leong, Darryl P. ;
Bangdiwala, Shrikant I. ;
Hart, Robert G. ;
Yusuf, Salim .
LANCET, 2018, 391 (10117) :219-229
[2]   Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI) [J].
Bainey, Kevin R. ;
Welsh, Robert C. ;
Connolly, Stuart J. ;
Marsden, Tamara ;
Bosch, Jackie ;
Fox, Keith A. A. ;
Steg, P. Gabriel ;
Vinereanu, Dragos ;
Connolly, Derek L. ;
Berkowitz, Scott D. ;
Foody, JoAnne M. ;
Probstfield, Jeffrey L. ;
Branch, Kelley R. ;
Lewis, Basil S. ;
Diaz, Rafael ;
Muehlhofer, Eva ;
Widimsky, Petr ;
Yusuf, Salim ;
Eikelboom, John W. ;
Bhatt, Deepak L. .
CIRCULATION, 2020, 141 (14) :1141-1151
[3]   Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes Mellitus and Cardiovascular Disease Insights From the COMPASS Trial [J].
Bhatt, Deepak L. ;
Eikelboom, John W. ;
Connolly, Stuart J. ;
Steg, P. Gabriel ;
Anand, Sonia S. ;
Verma, Subodh ;
Branch, Kelley R. H. ;
Probstfield, Jeffrey ;
Bosch, Jackie ;
Shestakovska, Olga ;
Szarek, Michael ;
Maggioni, Aldo Pietro ;
Widimsky, Petr ;
Avezum, Alvaro ;
Diaz, Rafael ;
Lewis, Basil S. ;
Berkowitz, Scott D. ;
Fox, Keith A. A. ;
Ryden, Lars ;
Yusuf, Salim .
CIRCULATION, 2020, 141 (23) :1841-1854
[4]   Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis [J].
Bhatt, Deepak L. ;
Eagle, Kim A. ;
Ohman, E. Magnus ;
Hirsch, Alan T. ;
Goto, Shinya ;
Mahoney, Elizabeth M. ;
Wilson, Peter W. F. ;
Alberts, Mark J. ;
D'Agostino, Ralph ;
Liau, Chiau-Suong ;
Mas, Jean-Louis ;
Roether, Joachim ;
Smith, Sidney C., Jr. ;
Salette, Genevieve ;
Contant, Charles F. ;
Massaro, Joseph M. ;
Steg, Ph. Gabriel .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (12) :1350-1357
[5]   Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease The COMPASS Trial [J].
Branch, Kelley R. ;
Probstfield, Jeffrey L. ;
Eikelboom, John W. ;
Bosch, Jackie ;
Maggioni, Aldo P. ;
Cheng, Richard K. ;
Bhatt, Deepak L. ;
Avezum, Alvaro ;
Fox, Keith A. A. ;
Connolly, Stuart J. ;
Shestakovska, Olga ;
Yusuf, Salim .
CIRCULATION, 2019, 140 (07) :529-537
[6]   Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial [J].
Connolly, Stuart J. ;
Eikelboom, John W. ;
Bosch, Jackie ;
Dagenais, Gilles ;
Dyal, Leanne ;
Lanas, Fernando ;
Metsarinne, Kaj ;
O'Donnell, Martin ;
Dans, Anthony L. ;
Ha, Jong-Won ;
Parkhomenko, Alexandr N. ;
Avezum, Alvaro A. ;
Lonn, Eva ;
Liu Lisheng ;
Torp-Pedersen, Christian ;
Widimsky, Petr ;
Maggioni, Aldo P. ;
Felix, Camilo ;
Keltai, Katalin ;
Hori, Masatsugu ;
Yusoff, Khalid ;
Guzik, Tomasz J. ;
Bhatt, Deepak L. ;
Branch, Kelley R. H. ;
Bruns, Nancy Cook ;
Berkowitz, Scott D. ;
Anand, Sonia S. ;
Varigos, John D. ;
Fox, Keith A. A. ;
Yusuf, Salim .
LANCET, 2018, 391 (10117) :205-218
[7]   Association of Multiple Enrichment Criteria With Ischemic and Bleeding Risks Among COMPASS-Eligible Patients [J].
Darmon, Arthur ;
Sorbets, Emmanuel ;
Ducrocq, Gregory ;
Elbez, Yedid ;
Abtan, Jeremie ;
Popovic, Batric ;
Ohman, E. Magnus ;
Roether, Joachim ;
Wilson, Peter F. ;
Montalescot, Gilles ;
Zeymer, Uwe ;
Bhatt, Deepak L. ;
Steg, Philippe Gabriel .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (25) :3281-3291
[8]   External applicability of the COMPASS trial: an analysis of the reduction of atherothrombosis for continued health (REACH) registry [J].
Darmon, Arthur ;
Bhatt, Deepak L. ;
Elbez, Yedid ;
Aboyans, Victor ;
Anand, Sonia ;
Bosch, Jackie ;
Branch, Kelley R. ;
Connolly, Stuart. J. ;
Dyal, Leanne ;
Eikelboom, John W. ;
Fox, Keith A. A. ;
Keltai, Katalin ;
Probstfield, Jeffrey ;
Yusuf, Salim ;
Abtan, Jeremie ;
Sorbets, Emmanuel ;
Eagle, Kim A. ;
Ducrocq, Gregory ;
Steg, Philippe Gabriel .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :750-+
[9]   COMPASS criteria applied to a contemporary cohort of unselected patients with stable coronary artery diseases: insights from the START registry [J].
De Luca, Leonardo ;
Formigli, Dario ;
Meessen, Jennifer ;
Uguccioni, Massimo ;
Cosentino, Nicola ;
Paolillo, Claudio ;
Di Lenarda, Andrea ;
Colivicchi, Furio ;
Gabrielli, Domenico ;
Gulizia, Michele M. ;
Scherillo, Marino ;
Maras, P. .
EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2021, 7 (05) :513-520
[10]   Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease [J].
Eikelboom, J. W. ;
Connolly, S. J. ;
Bosch, J. ;
Dagenais, G. R. ;
Hart, R. G. ;
Shestakovska, O. ;
Diaz, R. ;
Alings, M. ;
Lonn, E. M. ;
Anand, S. S. ;
Widimsky, P. ;
Hori, M. ;
Avezum, A. ;
Piegas, L. S. ;
Branch, K. R. H. ;
Probstfield, J. ;
Bhatt, D. L. ;
Zhu, J. ;
Liang, Y. ;
Maggioni, A. P. ;
Lopez-Jaramillo, P. ;
O'Donnell, M. ;
Kakkar, A. K. ;
Fox, K. A. A. ;
Parkhomenko, A. N. ;
Ertl, G. ;
Stoerk, S. ;
Keltai, M. ;
Ryden, L. ;
Pogosova, N. ;
Dans, A. L. ;
Lanas, F. ;
Commerford, P. J. ;
Torp-Pedersen, C. ;
Guzik, T. J. ;
Verhamme, P. B. ;
Vinereanu, D. ;
Kim, J. -H. ;
Tonkin, A. M. ;
Lewis, B. S. ;
Felix, C. ;
Yusoff, K. ;
Steg, P. G. ;
Metsarinne, K. P. ;
Bruns, N. Cook ;
Misselwitz, F. ;
Chen, E. ;
Leong, D. ;
Yusuf, S. ;
Aboyans, V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) :1319-1330